Laurion Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2025
         Q2  | $249K | Buy | 
         | 
    |||||
| 
        
          
      
        2024
         Q3  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2024
         Q2  | $809K | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q4  | – | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | – | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $503K | Buy | 
         | 
    |||||
| 
        
          
      
        2021
         Q2  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | $4.18M | Sell | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $34.1M | Buy | 
         | 
    |||||
| 
        
          
      
        2020
         Q1  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2019
         Q4  | $8.01M | Buy | 
         | 
    |||||
| 
        
          
      
        2019
         Q3  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2019
         Q2  | $1.81M | Buy | 
         | 
    |||||
| 
        
          
      
        2019
         Q1  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2018
         Q4  | $6.03M | Buy | 
         | 
    |||||
| 
        
          
      
        2018
         Q3  | $668K | Buy | 
         | 
    |||||
| 
        
          
      
        2016
         Q4  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2016
         Q3  | $362K | Sell | 
         | 
    |||||
| 
        
          
      
        2016
         Q2  | $349K | Sell | 
         | 
    |||||
| 
        
          
      
        2016
         Q1  | $812K | Buy | 
         |